| Page 2059 | Kisaco Research
 

Laurence Cooper

Chief Executive Officer
Ziopharm

Laurence Cooper

Chief Executive Officer
Ziopharm

Laurence Cooper

Chief Executive Officer
Ziopharm
 

Michael Poisel

Penn Center for Innovation

Michael Poisel

Penn Center for Innovation

Michael Poisel

Penn Center for Innovation
 

Gary Sclar

Dana Farber Innovations

Gary Sclar

Dana Farber Innovations

Gary Sclar

Dana Farber Innovations
 

Ronald Dudek

Living Pharma

Ronald Dudek

Living Pharma

Ronald Dudek

Living Pharma
 

James Noble

CEO
Adaptimmune

James Noble

CEO
Adaptimmune

James Noble

CEO
Adaptimmune
 

Karim Helmy

Vice President
Venrock

Karim Helmy

Vice President
Venrock

Karim Helmy

Vice President
Venrock
 

Stefan Jennewein

Managing Director
Jennewein

Dr. Stefan Jennewein studied Biochemistry, Pharmacology and Organic Chemistry at the Universities of Sussex (Brighton, UK), Zurich (CH), Tübingen (D) and Cambridge (UK), and at the Ludwig-Maximilians-Universität (Munich, D), where he obtained a PhD. He also gained practical experience through his work at Washington State University (Pullman, USA), the company DSM N.V. (Delft, NL), the Technical University of Darmstadt (D), and the Fraunhofer Institute for Molecular Biology and Applied Ecology (Aachen, D) as the Head of  the Department of Industrial Biotechnology. Dr.

Stefan Jennewein

Managing Director
Jennewein

Stefan Jennewein

Managing Director
Jennewein

Dr. Stefan Jennewein studied Biochemistry, Pharmacology and Organic Chemistry at the Universities of Sussex (Brighton, UK), Zurich (CH), Tübingen (D) and Cambridge (UK), and at the Ludwig-Maximilians-Universität (Munich, D), where he obtained a PhD. He also gained practical experience through his work at Washington State University (Pullman, USA), the company DSM N.V. (Delft, NL), the Technical University of Darmstadt (D), and the Fraunhofer Institute for Molecular Biology and Applied Ecology (Aachen, D) as the Head of  the Department of Industrial Biotechnology. Dr. Stefan Jennewein is the Founder & CEO of Jennewein Biotechnologie GmbH

How Human Biotechs can Benefit from Collaborations with Animal Health Organizations